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A B S T R A C T   
Management of chronic diabetic ulcers remains as a major challenge in healthcare which requires extensive 
multidisciplinary approaches to ensure wound protection, management of excess wound exudates and pro-
moting healing. Developing wound healing patches that can act as a protective barrier and support healing is 
highly needed to manage chronic diabetic ulcers. In order to boost the wound healing potential of patch ma-
terial, bioactive agents such as growth factors can be used. Porous membranes made of nanofibers generated 
using electrospinning have potential for application as wound coverage matrices. However, electrospun mem-
branes produced from several biodegradable polymers are hydrophobic and cannot manage the excess exudates 
produced by chronic wounds. Gelatin-methacryloyl (GelMA) hydrogels absorb excess exudates and provide an 
optimal biological environment for the healing wound. Epidermal growth factor (EGF) promotes cell migration, 
angiogenesis and overall wound healing. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) membranes 
provide microbial, thermal and mechanical barrier properties to the wound healing patch. Herein, we developed 
a biodegradable polymeric patch based on the combination of mechanically stable electrospun PHBV, GelMA 
hydrogel and EGF for promoting diabetic wound healing. In vitro and in vivo studies were carried out to evaluate 
the effect of developed patches on cell proliferation, cell migration, angiogenesis and wound healing. Our results 
showed that EGF loaded patches can promote the migration and proliferation of multiple types of cells (kera-
tinocytes, fibroblasts and endothelial cells) and enhance angiogenesis. In situ development of the patch and 
subsequent in vivo wound healing study in diabetic rats showed that EGF loaded patches provide rapid healing 
compared to control wounds. Interestingly, 100 ng EGF per cm2 of the patches was enough to provide favourable 
cellular response, angiogenesis and rapid diabetic wound healing. Overall results indicate that EGF loaded 
PHBV-GelMA hybrid patch could be a promising approach to promote diabetic wound healing.   
1. Introduction 
Wound healing remains a major challenge in diabetic patients that 
results in morbidity and mortality due to several complications such as 
systemic inflammatory responses, severe sepsis and amputation of 
limbs [1]. Approximately 20% of all diabetic patients suffer from 
chronic ulcers at least once in their lifetime [2,3]. Co-occurrence of 
peripheral neuropathy and vascular diseases in diabetic patients in-
crease the chances of ulceration due to loss of pain-sensation and per-
ipheral ischemia [4–6]. Presence of significantly larger population of 
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inflammatory cells which produce proteases like matrix metallopro-
teinases (MMPs) result in a shortage of growth factors that provide the 
cues for cell proliferation, migration, angiogenesis and wound healing 
[7]. Localized delivery of growth factors in diabetic ulcers offer great 
promise for optimal wound management as they activate various cel-
lular responses such as cell migration, proliferation, and differentiation 
to facilitate rapid wound healing [8,9]. As a result of the excellent 
mitogenic effects on epithelial, fibroblastoid, and endothelial cells, 
epidermal growth factor (EGF) is used in clinics as a wound healing 
agent [10]. There are several reports on the topical application of EGF 
on cutaneous wounds for facilitating rapid wound healing [11,12]. 
Since the chronic wound microenvironment is hostile for local EGF 
bioavailability, administration of EGF in the diabetic wounds using a 
biopolymeric patch could be a promising approach to provide its long- 
term bioactivity. 
In order to reduce the complications of diabetic wounds, wound 
healing patches with exudate uptake capacity, ability to prevent pa-
thogenic invasion and wound healing properties should be applied over 
the wound [13,14]. The application of a suitable biodegradable patch 
could be a robust approach for protecting the wound and promoting 
wound healing. Several synthetic and natural polymers have been used 
for the development of degradable wound healing patches to manage 
chronic diabetic wounds [15–17]. Additionally, hydrogels attract in-
creasing interest in wound healing applications since they can be ap-
plied directly on the wound which allows them to align perfectly with 
wound margins [6,18,19]. Hydrogels can hold a high water content and 
can thus absorb exudates at the wound site; this offers ideal conditions 
for skin hydration, healing, and removing necrotic tissue [20–23]. On 
the other hand, Gelatin-methacryloyl (GelMA) based wound healing 
patches are highly promising for wound healing applications due to 
their biocompatibility, biodegradability, low cost and simplicity of 
processing [24–28]. In addition, GelMA has received wide acceptance 
for the encapsulation and localized delivery of bioactive agents like 
growth factors [29–31]. However, the ability of GelMA to form a 
physical barrier over the wound for the entire duration of healing is 
limited due to its inferior mechanical strength and relatively fast de-
gradation [32–34]. In order to ensure the complete success of wound 
healing patch during its entire period, a practical design that relies on 
multiple components is required. Incorporation of agents that can en-
hance healing will be necessary to achieve the desired outcome in 
chronic wound healing. Therefore, incorporation of bioactive agents 
such as EGF in GelMA component of the patch could be a good ap-
proach to improve the biological performance of the patch such as host 
cells proliferation, enhancement of cell migration to wounded area and 
enhanced angiogenesis at the application site [35,36]. 
Use of a secondary support material over the GelMA hydrogel layer 
with a relatively hydrophobic and mechanically stable polymer could 
be a promising strategy to protect the wound bed from pathogenic 
microorganisms and facilitate healing. Poly(3-hydroxybutyrate-co-3- 
hydroxyvalerate) (PHBV) can be a good candidate for this purpose 
because of its biocompatibility, biodegradability and mechanical 
strength [37]. PHBV is already explored in many biomaterial applica-
tions such as drug delivery systems, tissue engineering scaffolds and 
wound dressings [38]. An interesting study indicated that PHBV na-
nofiber meshes were able to promote wound healing and mitigate scar 
formation [39]. Although hydroxyvalerate content in PHBV can en-
hance the degradation and cell proliferation for some extent [40], this 
alone is not sufficient to make it a suitable biomaterial for wound 
healing applications [41]. Approaches like blending with other natural 
polymers [42], bioactive proteins [43], surface treatment [44], loading 
nanoparticles [45,46] are being tried to improve the wound healing 
performance of PHBV based wound dressings or patches. 
Electrospinning technique can be used for the fabrication of highly 
porous membranes composed of fibers with submicrometer-diameter 
from a wide range of natural and synthetic polymers [47]. In addition 
to wound healing applications [48–51], electrospun membranes are 
used in several biomaterial applications such as drug delivery systems 
[8], tissue engineering scaffolds [52–57] and biomedical implants 
[58,59]. Electrospun membranes can effectively prevent the pathogenic 
colonization in wounds due to their microbial barrier property asso-
ciated with closely packed fiber network [60]. Moreover electrospun 
fibers can act as cell guidance channels to facilitate the migration of 
neighboring host cells to the healing wound [45]. Thus, we herein re-
port the development of EGF loaded wound healing patch based on 
GelMA hydrogel and PHBV meshes for diabetic wound healing appli-
cations. The developed patches were tested for cell proliferation and 
viability using fibroblasts and keratinocytes. In vivo studies in mice 
demonstrated that EGF loaded patches promoted cell proliferation, cell 
migration, angiogenesis and diabetic wound healing. Obtained results 
suggest that EGF-containing hybrid patches have remarkable potential 
for diabetic wound healing applications. 
2. Experimental section 
2.1. Fabrication of PHBV membranes 
For electrospinning, 20% w/v PHBV (Mw = 6,80,000 gmol−1, 12% 
PHV content, Sigma Aldrich) solutions were prepared in chloroform/ 
DMF mixture (9:1). The prepared solution was taken in 10 mL syringe 
with an 18-gauge needle and electrospun at 15 cm tip to collector 
distance. A stationary steel plate was used as the collector. A flow rate 
of 2.5 mL·h−1 and 18 kV DC voltage were maintained during the 
electrospinning process. Obtained membranes were removed from the 
collector plate and used for the preliminary characterization and de-
velopment of hybrid patches. 
2.2. Development of EGF loaded hybrid patches 
GelMA was synthesized as described in an earlier report [61]. 
Briefly, gelatin (Type A) was dissolved in PBS at 60 °C and 8 mL MA was 
added for every 100 mL of gelatin solution under vigorous stirring 
(50 °C) and the reaction was continued for 3 h. The reaction was 
stopped by adding excess preheated PBS (50 °C). The solution was then 
dialyzed and then freeze-dried to obtain GelMA. GelMA solutions were 
prepared by vortexing the required amount of GelMA to get 5% w/v 
solution in phosphate-buffered-saline (PBS, pH 7.4). All GelMA solu-
tions contained a final concentration of 0.5% (w/v) 2-hydroxy-4′-(2- 
hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959). Detailed in-
formation regarding the optimization studies of GelMA hydrogel pre-
paration can be found in our earlier publication [17]. To produce bi- 
layered patch, PHBV meshes were immersed in PBS for 1 h. Then, 
200 μL GelMA solution was taken on a glass cover slip, wet PHBV 
membranes (2 × 2 cm) were kept over the GelMA droplet and gently 
pressed for 30 s to facilitate the infiltration of the solution into the pores 
of the membrane and obtain hybrid PHBV-GelMA patches. To get EGF 
loaded patches, four EGF concentrations were used, namely, 25 ng/ 
cm2, 50 ng/cm2, 100 ng/cm2 and 150 ng/cm2 which were mixed with 
the GelMA solution just before infiltration in scaffolds. The GelMA in 
the hybrid patches was stabilized by UV crosslinking (Omnicure S2000, 
10 s, 500 nm, 7 mwWcm−2). Fabricated hybrid meshes were washed in 
ultrapure water for 5 min to remove unreacted reagents. Although we 
developed patches containing four different concentrations of EGF, 
based on the preliminary in vitro cell culture experiments (Supporting 
Information, Figs. S1–S3), hybrid patches containing 100 ng/cm2 EGF 
(denoted as PHBV-GelMA-EGF) were only used for detailed analysis. In 
order to further verify the effective loading of EGF, we tested the 
loading of rhodamine conjugated bovine serum albumin as a model 
protein (Details are provided in supporting information, Fig. S4). 
2.3. Physical characterization of the patches 
The morphology of the developed PHBV meshes and hybrid patches 
R. Augustine, et al.   Materials Science & Engineering C 118 (2021) 111519
2
was investigated using a scanning electron microscope (SEM). Before 
the analysis, patches were dried in a hot air oven (40 °C) for 24 h, and 
then sputter coated with gold for a few minutes. Gold coated samples 
were analyzed using FEI, Nova NanoSEM, 450 FE-SEM at 10 kV. 
Average fiber diameter was obtained from the electron micrographs 
using ImageJ software. X-Ray Diffractometer (XRD, MiniFlex, Rigaku, 
Tokyo, Japan, 2θ range 0–60°, 40 KV voltage, 30 mA current) was used 
to determine the presence of GelMA coating on the meshes. Fourier 
transform infrared (FT-IR) analysis of PHBV meshes, GelMA and pat-
ches was performed with a Perkin Elmer Frontier MIR spectro-
photometer with a PIKE Gladi ATR (USA) attachment at 4 cm−1 re-
solution in the range 4000–400 cm−1. 
2.4. Mechanical strength 
The tensile properties of PHBV meshes, PHBV-GelMA patches and 
PHBV-GelMA-EGF patches were determined by uniaxial tensile tests of 
samples with a size of 6 × 1 cm2 under a displacement rate of 1 mm/ 
min. The thickness of the samples was 1.4  ±  0.2 mm. The Young's 
modulus of patches was defined as the slope of linear elastic region of 
the stress-strain curves. 
2.5. Swelling characterization and determination of water contact angle 
2.5.1. Swelling 
Swelling study of the patches were performed to understand the 
exudate uptake capacity of the patches. Accurately weighed dry PHBV 
meshes and hybrid patches were soaked in PBS at 37 °C for different 
time intervals until fully hydrated and weighed again to get the wet 
weight of the samples. The swollen samples were then washed with 
distilled water (3 times), dried in a hot air oven (40 °C for 5 days), and 
reweighed. The swelling (%) was calculated by the Eq. (1). =Swelling (%) [(W W )/W ] x 100W D D (1) 
where WW and WD are the wet and dry weight of the membranes re-
spectively. 
2.5.2. Water contact angle 
Hydrophilicity of the patches were obtained from the water contact 
angle measurements (Phoenex-KGV-5000). A small water droplet was 
kept on the surface of PHBV, PHBV-GelMA or PHBV-GelMA-EGF sam-
ples (2 × 2 cm). Contact angle between the water droplet and the 
samples were automatically taken by the machine. The experiments 
were performed at 26 °C and about 60% relative humidity. 
2.6. In vitro cell culture studies 
2.6.1. Cytocompatibility and cell proliferation 
The cytocompatibility and cell proliferation were investigated with 
HaCat keratinocytes (Passage-24), 3T3 Fibroblasts (ATCC CRL-1658, 
Passage-28), and EA.hy926 endothelial cells (ATCC CRL-2922, Passage- 
17). Cells were seeded on PHBV meshes and hybrid patches with 
1 × 1 cm dimensions at a density of 2 × 104 cells/sample and cultured 
in 24-well plates. The patches were sterilized by 70% ethanol treatment 
and UV irradiation (15 min). All cells were maintained in DMEM 
(Gibco, Ireland) containing 10% fetal bovine serum and 1% penicillin/ 
streptomycin solution (Gibco, US origin). Cell seeded patches were kept 
up to 7 days in an incubator with 5% CO2 at 37 °C. To assess the cy-
tocompatibility of the cells on the developed membranes, Live/Dead 
staining (Molecular Probes, Invitrogen, USA) was carried out according 
to the manufacturer's instructions (n = 3). Cells proliferated over the 
patches were imaged using an Olympus, FV300 fluorescent microscope. 
Percentage of viable cells on the patches were calculated from the 
microscopic images using Eq. (2). =Viable cells (%) Live cells/Total cells x 100 (2)  
For MTT assay, cell seeded membranes (as described in the case of 
Live/Dead staining) were kept in 5% CO2 incubator up to 7 days, and 
MTT assay was performed as per the instructions of manufacturer 
(Molecular Probes, Invitrogen, USA). Absorbance of the solution was 
recorded at 570 nm using a microplate reader (Infinite F200 PRO, 
Tecan, Switzerland). 
Viability of cells on the patches were calculated using Eq. (3). =Cell viability (%) (OD of sample/OD of control) x 100 (3)  
2.6.2. In vitro wound healing scratch assay 
The in vitro wound healing scratch test was performed using 3T3 
fibroblasts, HaCat keratinocytes and EA.hy926 endothelial cells to de-
termine the effect of EGF loaded patches on keratinocyte cell migration. 
In each independent experiments using different cell lines, cells were 
grown in 24-well cell culture plates in DMEM medium and the test was 
performed using previously reported protocol [62]. Briefly, after re-
moving the medium, scratches were made on the confluent layer of 
cells over the plates using 100 μL pipet tips. After gentle washing to 
remove the floating cells, samples were placed over the scratches, fresh 
media was added and incubated in a CO2 incubator (37 °C, 5% CO2 
supply). Images of the plates were captured with an inverted micro-
scope (Leica DMi1) immediately after the experiment and after 18 h. In 
vitro wound healing (%) was determined by quantifying the cell free 
scratched area using Eq. (4). =In vitro Wd Wd Wdwound healing (%) ( – )/0 t 0 (4)  
Whereas Wd0 and Wdt are the average distance between scratch 
boarders soon after wounding procedure and after time ‘t’ of treatment. 
We also performed DAPI-Phalloidin staining of cells after the com-
pletion of experiment to see the variation in cell morphology. 
2.7. Determination of the angiogenic potential of the patches 
The ability of developed patches to induce angiogenesis was studied 
by chorioallantoic membrane (CAM) assay as described in the earlier 
reports [63,64]. Briefly, fertilized chicken eggs were purchased from 
Arab Qatari for Poultry Production, Shamal Road, Farm Street, Qatar 
and incubated for 4 days in an egg incubator (1502-Digital Sportsman, 
GQF Manufacturing Company Inc.). A 1.5 cm diameter window was 
created on the top of the eggshell to provide access to the CAM. Sterile 
samples of PHBV-GelMA and PHBV-GelMA-EGF hybrid patches were 
deposited on the CAM. The eggs were placed in the incubator for 24 h in 
a static position. After 24 h, the CAMs were observed under stereo-
microscope (Stemi 508) for angiogenesis and photographs were taken. 
The number of junctions and the diameter of blood vessel were quan-
tified using ImageJ software. 
2.8. Evaluation of direct application and diabetic wound healing potential in 
rats 
Male Sprague Dawley rats with average weight of 220 g were se-
lected for the diabetic wound healing study. The rat breed used in this 
study was sourced from Kerala Veterinary and Animal Sciences 
University, Mannuthy, India. Wound healing study was performed by 
strictly adhering to the guidelines of CPCSEA established by the 
Ministry of Environment, Forests and Climate Change, Animal Welfare 
Division of Government of India and with the prior approval of 
Institutional animal ethics committee (No.602/PO/Re/S/2002/ 
CPCSEA) of Pushpagiri Institute of Medical Sciences and Research 
Centre, Tiruvalla, Kerala, India. 
Induction of diabetes in rats was achieved by the intraperitoneal 
injection of streptozotocin (40 mg/kg body weight, Sigma Aldrich, 
USA). Glucose level in blood was monitored to understand the suc-
cessful development of diabetes in rats as described in our earlier report 
[45]. Rats were anaesthetized by the intraperitoneal administration of 
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ketamine hydrochloride (50 mg/kg) and xylazine (5 mg/kg). After 
surface disinfection with alcohol, two 1.5 × 1.5 cm skin excision 
wounds (full thickness) were created at distance of 3 cm from each 
other on the dorsal region of the rats. The patches were developed on 
the wound by in situ crosslinking of GelMA (Fig. 8A). Photographs of 
some of the key steps during the in situ development of the patch are 
given in Supporting Information, Fig. S5. Prior to the application, PHBV 
meshes (1.5 × 1.5 cm) were sterilized as reported in a previous pub-
lication [65]. GelMA solutions containing photoinitiator were prepared 
as described in Section 2.2. To produce bi-layered patch, PHBV meshes 
were immersed in PBS for 1 h. Then, 150 μL GelMA solution was ap-
plied over the wounds, wet PHBV membranes were placed over the 
GelMA droplet and gently pressed for 30 s to facilitate the infiltration of 
the solution into the pores of the membrane and obtain hybrid PHBV- 
GelMA patches over the wound. To get EGF loaded patches, EGF was 
loaded in GelMA solution in such a way that 100 ng/cm2 EGF was 
present in hybrid patches (PHBV-GelMA-EGF). The GelMA in the hybrid 
patches was stabilized by UV crosslinking for 3 min using a Elipar™ 
DeepCure-S LED Curing Light at 5 cm distance. Wounds were covered 
with polyurethane film and dry nonadherent gauze. The wounds were 
then covered with a gauze bandage roll and an adhesive elastic ban-
dage. Each day the outer dressings were removed and the wounds were 
visually inspected for the evidence of infection if any. Photographic 
images of the wounds were captured at regular intervals up to 30 days 
to understand the physical appearance and rate of wound contraction. 
The wound contraction (%) was quantified using Eq. (5). =Wound contraction (%) [(WA WA)/WA ] x 1000 t 0 (5) 
where ‘WA0’ is the area of wound at 0th day (same day of wound 
generation) and ‘WAt’ is the area of wound at ‘t’ days of healing. 
Skin was excised from the healed area after 30 days of study and 
used for histopathological analysis. The sections were stained with 
hematoxylin and eosin and for cellular infiltration, re-epithelialization 
and angiogenesis with a Leica light microscope. 
2.9. Statistical analysis 
All the experiments were performed for minimum 3 times and the 
results were reported as mean  ±  S.D. The statistical analysis was 
performed using the un-paired Student's t-test using Graph-Pad 
QuickCalcs (https://www.graphpad.com/quickcalcs/ttest1.cfm). P 
value less than 0.05 was considered as statistically significant. 
3. Results 
3.1. Morphology of the patches 
The morphology of uncoated PHBV membranes and PHBV-GelMA 
membranes were examined by SEM analysis. Neat PHBV membranes 
showed the presence of randomly oriented fibers with average diameter 
of 0.9  ±  0.6 μm (Fig. 1A). PHBV-GelMA showed the coating of PHBV 
fibers with GelMA hydrogel (Fig. 1B). The presence of GelMA coating 
over PHBV fibers considerably modified the fiber diameter as evident 
from Fig. 1C and D. GelMA infiltrated PHBV meshes showed 
3.5  ±  1.8 μm diameter. Loading of different concentrations of EGF in 
GelMA did not influence the overall morphology or fiber diameter of 
patches (Data not shown). 
3.2. XRD and FTIR analysis 
The XRD patterns of the neat PHBV, crosslinked GelMA, PHBV- 
GelMA and PHBV-GelMA-EGF samples are shown in Fig. 2A. The peaks 
at 13.50 and 16.90 correspond to α phase of PHBV polymer [66]. The 
XRD profile of the GelMA showed only broad peak at 2θ angle 320 
attributed to polymer networks as reported in an earlier study [67]. The 
PHBV-GelMA hybrid patches showed the prominent peaks of PHBV and 
GelMA (marked by arrows in Fig. 2A). We did not observe a remarkable 
difference in the XRD patterns of PHBV-GelMA and PHBV-GelMA-EGF 
patches. This is plausible because nanogram quantities of EGF cannot 
be detected from the background diffraction of polymers. 
FTIR analysis of the patches in attenuated total reflectance (ATR) 
mode was performed to examine the surface chemistry of PHBV, 
GelMA, PHBV-GelMA and GeLMA-PHBV-EGF fibers (Fig. 2B). The 
prominent band present around 1747 cm−1 indicated the stretching 
vibration of ester carbonyl groups (C=O) of PHBV [68]. The band 
observed at 1452 cm−1 indicated the asymmetric deformation of me-
thylene groups. Band at 1380 cm−1 was due to the symmetrical wag-
ging of CH3 groups. Another major band at 1177 cm−1 could be as-
signed to the amorphous regions of PHBV. In addition, characteristic 
bands of symmetric –C–O–C– stretching vibration were present from 
650 cm−1 to 1200 cm−1 whereas the antisymmetric –C–O–C–stretching 
bands were observed between 1050 and 1160 cm−1. Characteristic 
amide bands of gelatin was observed in the FTIR spectra of GelMA such 
as NeH stretching vibration around 3310 cm−1 for the amide A, CeH 
stretching vibration around 3063 cm−1 for amide B, C]O stretching 
vibration around 1657 cm−1 for amide I, NeH deformation band 
around 1555 cm−1 for amide II and NeH deformation band around 
1239 cm−1 for amide III [69]. The presence of some of the major FTIR 
bands of GelMA and PHBV in hybrid patches indicated the successful 
coating of GelMA on the surface of the PHBV fibers in hybrid patches. 
Small quantities of EGF were not detectable in the FTIR spectra of 
PHBV-GelMA-EGF loaded patches. 
3.3. Uniaxial tensile strength 
Fig. 3A-D shows the tensile stress–strain curves and calculated 
tensile properties of the patches. PHBV meshes showed a characteristic 
stress–strain behavior with a linearly elastic region at low strain region 
and deformation before breaking. Elongation at break of pure PHBV 
meshes, PHBV-GelMA and PHBV-GelMA-EGF patches were between 
130% and 160% without a statistically significant inter-group differ-
ence. However, ultimate tensile strength and Young's modulus of PHBV- 
GelMA and PHBV-GelMA-EGF were higher than that of bare PHBV 
meshes. PHBV meshes possessed an ultimate tensile stress of 
1.62  ±  0.3 MPa. PHBV-GelMA and PHBV-GelMA-EGF patches showed 
an ultimate tensile stress of 3.14  ±  0.43 MPa and 2.46  ±  0.3 MPa, 
respectively. Furthermore, Young's moduli of GelMA infiltrated patches 
were higher than that of bare PHBV membranes. PHBV membranes 
possessed a Young's modulus of 7.34  ±  1.78 MPa. PHBV-GelMA and 
PHBV-GelMA-EGF patches showed a Young's moduli of 
16.28  ±  2.75 MPa and 14.84  ±  2.52 MPa, respectively. Comparable 
tensile properties observed for PHBV-GelMA and PHBV-GelMA-EGF 
patches indicate that the addition of a small amount of EGF could not 
modify the overall tensile behavior of the patches. However, infiltration 
of GelMA significantly improved the tensile strength and modulus of 
PHBV which could be attributed to the adhesion of adjacent fibers at 
their junctions with the help of GelMA which facilitated the uniform 
stress transfer between fibers. 
3.4. Swelling and surface hydrophilicity 
The ability of developed wound healing patches to absorb wound 
exudates without causing tissue maceration is very important particu-
larly for highly-exudating diabetic wounds. Results of swelling study of 
pure PHBV, PHBV-GelMA and PHBV-GelMA-EGF membranes are given 
in Fig. 4A. Bare PHBV membranes have shown a swelling between 
20.5  ±  4.7% and 56.6  ±  6.5% during the entire experimental period. 
Infiltration of GelMA largely increased the swelling of the patches. As 
expected, incorporation of EGF did not modify the swelling of PHBV- 
GelMA patches. 
The surface hydrophobicity of the patches can be determined from 
water contact angle measurement. Results of water contact angle 
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measurements of pure PHBV meshes, PHBV-GelMA and PHBV-GelMA- 
EGF patches are given in Fig. 4B. Pure PHBV possessed a relatively high 
contact angle (106  ±  12o) as an indication of its high surface hydro-
phobicity. GelMA infiltration resulted in the decrease of contact angle 
to 47  ±  8o owing to a higher wettability of GelMA. PHBV-GelMA-EGF 
showed a comparable contact angle as in the case of PHBV-GelMA 
(44  ±  11°). This variation in hydrophilicity of the patches upon GelMA 
infiltration indirectly supports the successful modification of the PHBV 
meshes with GelMA. 
Fig. 1. Morphological characterization of developed PHBV mesh and PHBV-GelMA patch. SEM image showing the morphology of PHBV mesh (A) and PHBV-GelMA 
patch (B). Fiber diameter distribution graphs of PHBV mesh (C) and PHBV-GelMA patch (D). 
Fig. 2. Physical characterizations of PHBV mesh and hybrid patch. XRD patterns (A) and FTIR spectra (B) of fabricated hybrid patches and PHBV mesh and 
crosslinked GelMA. 
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3.5. Cell viability and cell proliferation on the patches 
To understand the cytocompatability of various types of mammalian 
cells on the developed patches, fibroblasts, keratinocytes and en-
dothelial cells were grown on the patches and tested for cell viability 
and cell proliferation. Live/Dead test results are given in Fig. 5A 
(Quantification of viable cells from Live/Dead assay is given in Fig. S6). 
All tested cells were able to adhere and proliferate on bare PHBV me-
shes, but considerably less than those on the control tissue culture 
plates. Generally, adhesion and proliferation of all tested cells were 
higher on PHBV-GelMA patches compared to bare PHBV meshes. 
PHBV-GelMA-EGF patches showed relatively higher cell adhesion and 
Fig. 3. Uniaxial tensile mechanical properties of the developed PHBV meshes and PHBV-GelMA hybrid patches. Stress-strain curve (A), Elongation at break (B), 
Ultimate tensile stress (C) and Young's modulus (D) of PHBV, PHBV-GelMA and PHBV-GelMA-EGF hybrid patches. P- values were obtained from Student's t-test 
where (*) indicates a statistically significant difference (p ≤ 0.05) and NS indicates no statistically significant difference. 
Fig. 4. Swelling of PHBV mesh, PHBV-GelMA and PHBV-GelMA-EGF hybrid patches (A). Water contact angle measurements on neat PHBV meshes, PHBV-GelMA and 
PHBV-GelMA-EGF hybrid patches (B). P- values were obtained from Student's t-test where (*) indicates a statistically significant difference (p ≤ 0.05). 
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Fig. 5. Cytocompatibility and cell proliferation properties of developed patches. Live/Dead assay results indicating the adhesion and proliferation of fibroblast, 
keratinocyte and endothelial cells on PHBV, PHBV-GelMA and PHBV-GelMA-EGF patches (A). Results of MTT assay indicating the viability of 3T3 fibroblasts, HaCat 
keratinocytes and EA.hy926 endothelial cells which were grown in the presence of patches (B). (*) indicates the P-values where a statistically significant difference 
(p ≤ 0.05) is present. Scale bars: 200 μm. 
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proliferation than PHBV-GelMA patches. Fibroblasts showed con-
siderably higher cell proliferation on PHBV-GelMA-EGF compared to 
PHBV-GelMA patches. The difference in cell adhesion and proliferation 
between bare PHBV-GelMA-EGF and PHBV-GelMA hybrid patches was 
marginal in the case of keratinocyte cells. Endothelial cells showed 
higher cell adhesion and proliferation on PHBV-GelMA-EGF compared 
to PHBV-GelMA patches. However, the morphology of keratinocytes 
and endothelial cells cultured on PHBV-GelMA-EGF was considerably 
different compared to those cultured on PHBV-GelMA. Both cell lines 
became more elongated when cultured on EGF loaded patches. Con-
versely, in the case of fibroblast cells, despite the increased cell density, 
there was no visible difference in morphology when cultured on EGF 
loaded patches. Moreover, PHBV-GelMA and PHBV-GelMA-EGF 
showed the presence of only few dead cells (stained in red) in com-
parison with those observed on bare PHBV membranes. In addition, 
MTT cell viability assay was performed and the results are given in  
Fig. 5B to quantitatively measure cell proliferation in the presence of 
developed patches. Obtained results confirmed the improvement of cell 
proliferation when cultured in the presence of PHBV-GelMA and PHBV- 
GelMA-EGF patches. 
3.6. In vitro cell migration and wound contraction potential of the patches 
To investigate the ability of developed patches to promote cell 
migration and subsequent wound contraction, in vitro wound contrac-
tion test was performed [70] and the obtained results are given in Fig. 6 
(A-C). Magnified views of the images are provided in Supporting In-
formation, Figs. S7–S9. In the case of fibroblast cells, about 30% of 
wounded area were healed after 18 h of treatment in controls. Bare 
PHBV meshes also showed a similar trend of wound contraction. 
However, slightly higher wound contraction was detected for PHBV- 
GelMA patches (P ≤ 0.05). Unlike other cell lines, statistically sig-
nificant difference in wound contraction was observed for PHBV-GelMA 
treated HaCat cells. However, percentage of wound contraction for all 
tested cell lines were higher for PHBV-GelMA-EGF treatment groups 
(Fig. 6D). Cells that were treated with PHBV-GelMA-EGF patches 
showed elongated cell morphology, especially in the case of HaCat cells 
(Fig. 6E). 
3.7. Proangiogenic effect of the patches 
In order to understand the angiogenic potential of PHBV-GelMA- 
EGF patches, chicken embryo-based CAM assay was performed. Based 
on the obtained results of physicomechanical characterizations and in 
vitro cell culture experiments, we selected PHBV-GelMA and PHBV- 
GelMA-EGF patches for CAM angiogenesis test. Images of the CAM 
before and after the placement of the patches are provided in Fig. 7A. 
Quantitative measurement of fold increase of blood vessel junctions and 
Fig. 6. Cell migration and wound contraction results of developed patches in vitro for 3T3 fibroblast (A), HaCat keratinocytes (B), and EA.hy926 endothelial cells (C). 
Percentage of wound contraction after incubation with the developed patches (D). Morphological differences in keratinocytes which were cultured with PHBV and 
hybrid patches with or without EGF (E). (*) indicates the P-values where a statistically significant difference (p ≤ 0.05) is present. The images of in vitro wound 
healing were taken using 5× magnification (Scale bars: 500 μm). Black and Yellow dotted lines indicate the boundary of the wounds before sample treatment and 
after 18 h of treatment, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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blood vessel diameter is provided in Fig. 7B and C. Both controls and 
PHBV-GelMA patches showed relatively similar number of blood vessel 
junctions. PHBV-GelMA-EGF patches showed significantly higher 
number of capillary junctions compared to the controls and PHBV- 
GelMA treated groups (P  <  0.005). There was no significant difference 
in blood vessel diameter between controls and different treatment 
groups. 
3.8. Diabetic wound healing potential of hybrid patches 
To investigate the in situ applicability and the effect of EGF loaded 
patches on diabetic wounds, the PHBV-GelMA and PHBV-GelMA-EGF 
patches were directly developed on the wounds by in situ crosslinking of 
GelMA on wounds in diabetic rats (Fig. 8A). Photographs of the wounds 
were taken soon after the application of the patch and every other day 
until the wound was completely healed. Wounds covered with PHBV- 
GelMA-EGF patches have shown higher rate of wound healing com-
pared to PHBV-GelMA groups (P ≤ 0.05) (Fig. 8B and C). 
Histological examination of healed skin covered with hybrid pat-
ches showed the formation of an intact skin with epidermal and dermal 
structures (Fig. 8D). We did not observe very significant variation in the 
histological features of PHBV-GelMA and PHBV-GelMA-EGF patches. 
However, the healed wounds covered with PHBV-GelMA-EGF patches 
generated ra slightly thick epidermis. 
4. Discussion 
Many hydrogels and other biopolymers have been used to develop 
wound healing patches loaded with growth factors for the management 
of chronic wounds [71]. In this work, we developed a diabetic wound 
healing patch composed of GelMA as a soft layer loaded with EGF to 
support healing on electrospun PHBV meshes as mechanical barrier to 
protect the wound from the external environment. Developed patches 
showed excellent microbial barrier properties also (Supporting in-
formation, Table S1). The encapsulation of growth factors in protective 
hydrogel matrix from harsh wound microenvironments for chronic 
wound healing is well-studied in literature [72]. However, infiltration 
of photocrosslinkable GelMA hydrogel in electrospun membranes to 
develop constructs that release growth factors to facilitate cell pro-
liferation, cell migration, angiogenesis and wound healing is a novel 
approach. Direct in vivo photocrosslinking of GelMA present in the 
hybrid patch upon application in the wound can ensure the integration 
of patch with the tissue without suturing. 
PHBV-GelMA patches showed the effective coating of GelMA over 
PHBV fibers and the joining of fibers at their intersection. The GelMA 
coating largely increased the fiber diameter and changed the mor-
phology of the fibers. It is plausible that a coating of hydrogel over the 
surface can increase the diameter of the fibers [73]. SEM analysis of the 
patches clearly showed the close integration of coating on the PHBV- 
fiber surface. It is worth mentioning that the produced hybrid patches 
could mimic the morphological features of the extracellular matrix 
since elastin [74] and collagen [75] fibers found in natural ECM share 
many structural features of the obtained fibers. This similarity may help 
to provide necessary physical cues for cell adhesion, proliferation, mi-
gration and result in rapid wound healing [76]. It is also interesting to 
note that the improved and adequate tensile strength, flexibility and 
elasticity of hybrid patches were comparable with that of skin and can 
provide mechanical fitness to the defective area and avoid failure 
during muscular movements. Higher tensile strength and modulus va-
lues that were observed for the hybrid patches can be ascribed on the 
binding interaction between the fibers and GelMA due to the gluing 
effect of GelMA at the contact points between fibers [77]. We also 
observed an improvement in swelling capacity and hydrophilicity of 
PHBV meshes upon infiltration of GelMA. Higher fluid uptake in the 
beginning of the experiment and subsequent limited uptake shown by 
bare PHBV meshes might be due to the retention of PBS inside the large 
Fig. 7. Chicken chorioallantioic membrane angiogenesis assay. Photographs showing the angiogenic response after 24 h treatment with patches (A). Fold increase of 
junction (B) and fold increase of diameter (C) measured from the images of blood vessels. (*) indicates the P-values where a statistically significant difference 
(p ≤ 0.05) is present. (NS) indicates no statistically significant difference. 
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pore spaces of electrospun membranes. Higher fluid holding capacity of 
hybrid patches can be ascribed to the inherent hydrophilic nature of 
GelMA hydrogel present over PHBV fibers [78]. These findings are 
highly relevant towards wound healing applications of the hybrid 
patches because neither hydrophobic PHBV nor mechanically unstable 
GelMA can perform alone as a successful wound healing patch. In ad-
dition to the necessary exudate management capacity required in 
chronic wounds, higher cell proliferation and faster healing can be 
expected when such a hydrophilic patch is used on the wounds [73]. 
Earlier studies that indicate the positive impact of polymeric patches 
with hydrophilic property and exudate holding capacity on wound 
healing support our present findings [79]. 
It is essential to create an appropriate microenvironment with 
necessary cues for ensuring the proliferation of native cells migrating 
from wound edges towards the inner regions of the wound [16]. In 
order to promote cell proliferation and cell migration, we loaded EGF in 
GelMA hydrogel layer of the hybrid patches (PHBV-GelMA-EGF). Ear-
lier studies also demonstrated that the GelMA hydrogel can perform as 
an excellent material to hold and slowly release biomolecules such as 
growth factors for wound healing applications [80]. The adhesion, 
proliferation and viability of native cells such as keratinocytes, fibro-
blasts and endothelial cells within the wound healing patch are crucial 
for ensuring the fast healing of chronic wounds [81,82]. As we hy-
pothesized, the modification of PHBV membranes with GelMA hydrogel 
alone could improve the cell adhesion and proliferation up to a certain 
extent. However, incorporation of EGF resulted in the improvement of 
Fig. 8. Schematic representation showing the steps in wound healing evaluation of the patches (A). Representative photographs of the wounds covered with PHBV- 
GelMA and PHBV-GelMA-EGF hybrid patches showing the healing of full thickness excision wounds created on diabetic rats (B). Circles indicate PHBV-GelMA and 
doted circles indicate PHBV-GelMA-EGF hybrid patches. Rate of wound contraction (C) and the histological analysis of healed wound (D). Scale bars in histology 
images: 200 μm. 
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cell proliferation and viability to a great extent. In corroboration with 
our results, other studies also indicated that EGF can protect cells from 
apoptosis and promote their proliferation [83–85]. We also observed a 
clear variation in cell morphology upon treatment with EGF loaded 
patches compared to other patches which could be due to the activation 
of several cell motility associated genes and resulting epithelial-me-
senchymal transition (EMT) [86]. Cells that undergo EMT show an 
elongated mesenchymal like morphology [87]. As obvious, there was 
no distinguishable difference in cell morphology of fibroblasts treated 
with EGF loaded patches and controls as fibroblasts are already in 
mesenchymal phenotype [88]. EMT has a pronounced role in cell mi-
gration and wound healing [89]. EGF loaded patches produced a pro-
nounced effect on the migration of all tested cells and resulted in fast 
contraction of the experimentally created in vitro wounds. EGF has al-
ready been reported for its ability to produce a positive impact on the 
growth and migration of several types of mammalian cells such as oral 
epithelial cells [90], enterocytes [91], keratinocytes [92,93] and en-
dothelial cells [94,95]. Upon treatment with EGF loaded hybrid pat-
ches, cells (especially keratinocytes) showed a very pronounced varia-
tion in cell morphology (elongated morphology) during cell migration 
indicating EMT [96]. Since extent of re-epithelialization of wounds 
including chronic diabetic wounds depends upon the rate of cell mi-
gration from the margins of the wound, developed patches loaded with 
EGF with excellent cell migratory potential can be a good candidate for 
diabetic wound healing applications. 
Insufficient angiogenesis worsens the chronicity of diabetic wounds 
[97]. Higher angiogenesis was observed on CAM treated with EGF 
loaded patches. Other studies also indicated that EGF can promote 
angiogenesis [98,99]. Higher endothelial cell migration, proliferation 
and survival are required for mitigating impaired angiogenesis in dia-
betic wounds [100]. Higher viability and migration of endothelial cells 
might have played a major role in the observed higher angiogenesis 
response in chicken embryo CAM model. As evident from other studies, 
EGF might also have induced VEGF, a master regulator in angiogenesis, 
expression inother native cells in chicken embryo that resulted in in-
creased angiogenesis [101]. 
Our experiments revealed that PHBV-GelMA-EGF can produce faster 
wound closure than those patches without EGF. Observed higher dia-
betic wound healing might be due to the increased cell migration and 
cell proliferation induced by EGF as evident from our in vitro studies 
and other reported works [101,102]. It is interesting to note that the 
obtained results were comparable to that of diabetic wound healing rate 
observed when umbilical cord perivascular cell seeded acellulardermal 
matrix was used [103]. Obtained results for PHBV-GelMA-EGF were 
also comparable or slightly superior to that of exosome loaded hydrogel 
patches [104]. The histology showed a marginally higher epithelization 
in the PHBV-GelMA-EGF treated healed wounds compared to the 
PHBV-GelMA treated healed wounds. Moreover, in both cases, healed 
skin tissues showed almost complete re-epithelialization and formation 
of dermal tissues. Our earlier study clearly showed that a very thin 
epidermis and unorganized hypodermis were only formed when PHBV 
membranes alone were applied on the wounds [45]. However, com-
pared to the normal rat skin, a slightly thin epidermis was only formed 
in the healed skin tissue which were covered with hybrid patches [45]. 
This was expected due tothe fact that complete remodeling of skin can 
take several months. Moreover, it is almost impossible to achieve the 
complete regeneration of the original form and function of original skin 
by currently available approaches. However, fibrotic scars, which im-
pairs normal tissue organization and aesthetics, were minimum after 
the complete healing of wounds which were treated with the hybrid 
patches. 
Based on the obtained results of detailed physicomechanical and 
biological characterization, we propose that EGF loaded PHBV-GelMA 
hybrid patches with their flexible morphological features, good me-
chanical properties, ability to provide a niche for cell adhesion/pro-
liferation and cues for vascularization, are an effective candidate for 
diabetic wound healing applications. It was noteworthy that a small 
quantity of EGF in the PHBV-GelMA-EGF patches could provide a 
considerable improvement in the overall performance, suggesting their 
applicability as a cost-effective patch to effectively manage diabetic 
wounds. Although this work provides a detailed investigation with 
experimental evidence to show the application potential of PHBV- 
GelMA-EGF based patch for diabetic wound healing, a deeper in-
vestigation is still needed to understand the potential systemic effect of 
photoinitiator and other components directly exposed to the wound 
during the application. 
5. Conclusions 
In this work, hybrid wound healing patches based on electrospun 
PHBV meshes, GelMA and EGF were developed and thoroughly char-
acterized for physicochemical properties, in vitro biological perfor-
mance and in vivo wound healing potential. SEM analysis indicated that 
the developed patches were highly porous with the coating of GelMA. 
XRD and FTIR analyses demonstrated the formation of hybrid struc-
tured patches. Compared to bare PHBV meshes, hybrid patches showed 
optimal elasticity, tensile strength, and tensile modulus as suitable for 
wound healing applications. GelMA infiltrated hybrid patches showed 
higher exudate uptake capacity and hydrophilicity which are important 
for chronic wound healing applications. Higher fibroblasts, keratino-
cytes and endothelial cell proliferation and viability was observed upon 
treatment with EGF loaded hybrid patches. Hybrid patches loaded with 
EGF facilitated higher cell migration and resulted in fast in vitro wound 
closure. Compared to bare PHBV membranes, PHBV-GelMA patches 
and controls, EGF incorporated hybrid patches produced improved 
angiogenesis. Overall results indicate that EGF loaded GelMA hydrogels 
supported by PHBV meshes can be used as excellent diabetic wound 
healing patches. Finally, results of wound healing experiments using 
diabetic rats clearly showed the ability of EGF containing hybrid pat-
ches to enhance diabetic wound healing. Corroborating the desirable 
morphological features, mechanical properties, exudate management 
capacity, higher cell proliferation, proangiogenic property and ability 
to promote rapid diabetic wound healing, the developed PHBV-GelMA- 
EGF hybrid patches are highly promising for diabetic wound healing 
applications. 
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